Robert S. White - 10 Mar 2026 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Mar 2026, 08:52:43 UTC
Prior SEC filing
21 May 2025
Next SEC filing
20 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert S. White

Key filing fact

Robert S. White filed Form 4 for AtriCure, Inc. (ATRC) on 12 Mar 2026.

Key facts

  • This page summarizes Robert S. White's Form 4 filing for AtriCure, Inc. (ATRC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Mar 2026, 08:52.

Change

  • Previous filing in this sequence was filed on 21 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001571208 Primary reporting owner

WHITE ROBERT S.

Relationship
Director
Address
9060 ROCKY POINT DRIVE, VERO BEACH
Signature
/s/ Robert S. White
Signature date
12 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRC transaction

Common Stock

Options Exercise

Transaction value
Shares
+10,000
Change %
+8.9%
Price
$14.99*
Shares after
122,174
Date
10 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATRC transaction Derivative

Non-qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-10,000
Change %
-100%
Price
$14.99*
Shares after
0
Date
10 Mar 2026
Ownership
Direct
Underlying class
Non-qualified Stock Option (right to buy)
Underlying amount
10,000
Exercise price
$14.99
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options were granted on May 25, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .